At a clinical trial by the Memorial Sloan Kettering Cancer Center, a drug named Dostarlimab was administered to patients with rectal cancer, who have now been declared ‘cancer free’. Here’s all you need to know about the trial and the future of the study.
/english-betterindia/media/post_attachments/uploads/2022/06/clinical-trial-patients-1654685574.jpg)